Articles dans des revues avec comité de lecture (24)
  1. 1. De Fisenne, M.-A., Yilmaz, Z., De Decker, R., Suain, V., Buée, L., Ando, K., Brion, J. P., & Leroy, K. (2022). Alzheimer PHF-tau aggregates do not spread tau pathology to the brain via the Retino-tectal projection after intraocular injection in male mouse models. Neurobiology of disease, 174, 105875. doi:10.1016/j.nbd.2022.105875
  2. 2. Houben, S., De Fisenne, M.-A., Ando, K., Vanden Dries, V., Poncelet, L., Yilmaz, Z., Mansour, S., De Decker, R., Brion, J. P., & Leroy, K. (2020). Intravenous injection of PHF-Tau proteins from Alzheimer Brain exacerbates neuroinflammation, Amyloid beta, and tau pathologies in 5XFAD transgenic mice. Frontiers in Molecular Neuroscience, 13, 10.3389/fnmol.2020.00106, 106.
  3. 3. Ando, K., De Decker, R., Vergara Panos, C., Yilmaz, Z., Mansour, S., Suain, V., Sleegers, K., De Fisenne, M.-A., Houben, S., Potier, M.-C., Duyckaerts, C., Watanabe, T., Buée, L., Leroy, K., & Brion, J. P. (2020). Picalm reduction exacerbates tau pathology in a murine tauopathy model. Acta Neuropathologica, 139(4), 773-789. doi:10.1007/s00401-020-02125-x
  4. 4. Vergara Panos, C., Houben, S., Suain, V., Yilmaz, Z., De Decker, R., Vanden Dries, V., Boom, A., Mansour, S., Leroy, K., Ando, K., & Brion, J. P. (2019). Amyloid-β pathology enhances pathological fibrillary tau seeding induced by Alzheimer PHF in vivo. Acta Neuropathologica, 137(3), 397-412. doi:10.1007/s00401-018-1953-5
  5. 5. Vanden Dries, V., Stygelbout, V., Pierrot, N., Yilmaz, Z., Suain, V., De Decker, R., Buée, L., Octave, J. N., Brion, J. P., & Leroy, K. (2017). Amyloid precursor protein reduction enhances the formation of neurofibrillary tangles in a mutant tau transgenic mouse model. Neurobiology of aging. doi:10.1016/j.neurobiolaging.2017.03.031
  6. 6. Audouard, E., Houben, S., Masaracchia, C., Yilmaz, Z., Suain, V., Authelet, M., De Decker, R., Buée, L., Boom, A., Leroy, K., Ando, K., & Brion, J. P. (2016). High-Molecular-Weight Paired Helical Filaments from Alzheimer Brain Induces Seeding of Wild-Type Mouse Tau into an Argyrophilic 4R Tau Pathology in Vivo. The American journal of pathology, 186(10), 2709-2722. doi:10.1016/j.ajpath.2016.06.008
  7. 7. Heraud, C., Goufak, D., Ando, K., Leroy, K., Suain, V., Yilmaz, Z., De Decker, R., Authelet, M., Laporte, V., Octave, J. N., & Brion, J. P. (2013). Increased misfolding and truncation of tau in APP/PS1/tau transgenic mice compared to mutant tau mice. Neurobiology of disease, 62C, 100-112. doi:10.1016/j.nbd.2013.09.010
  8. 8. Ando, K., Leroy, K., Heraud, C., Yilmaz, Z., Authelet, M., Suain, V., De Decker, R., & Brion, J. P. (2011). Accelerated human mutant tau aggregation by knocking out murine tau in a transgenic mouse model. The American journal of pathology, 178(2), 803-816. doi:10.1016/j.ajpath.2010.10.034
  9. 9. Ando, K., Leroy, K., Heraud, C., Kabova, A., Yilmaz, Z., Authelet, M., Suain, V., De Decker, R., & Brion, J. P. (2010). Deletion of murine tau gene increases tau aggregation in a human mutant tau transgenic mouse model. Biochemical Society transactions, 38(4), 1001-1005. doi:10.1042/BST0381001
  10. 10. Leroy, K., Ando, K., Heraud, C., Yilmaz, Z., Authelet, M., Boeynaems, J.-M., Buée, L., De Decker, R., & Brion, J. P. (2010). Lithium treatment arrests the development of neurofibrillary tangles in mutant tau transgenic mice with advanced neurofibrillary pathology. Journal of Alzheimer's disease, 19(2), 705-719. doi:10.3233/JAD-2010-1276
  11. 11. Leroy, K., De Decker, R., Suain, V., Authelet, M., Yilmaz, Z., & Brion, J. P. (2009). C9 Tau et toxicité de l’amyloïde Aß dans les modèles transgéniques APP. Revue neurologique, 165(10), 23. doi:10.1016/S0035-3787(09)72562-7
  12. 12. Nicaise, C., Soyfoo, M. S., Authelet, M., De Decker, R., Bataveljic, D., Delporte, C., & Pochet, R. (2009). Aquaporin-4 overexpression in rat ALS model. The Anatomical Record, 292(2), 207-213. doi:10.1002/ar.20838
    13. << Précédent 1 2 3 4 5 6 Suivant >>